HELLP Syndrome: Diagnosis and Anesthesia Management

Definition and Pathophysiology

• Eclampsia (6%)
• Placental abruption (10%)
• Acute renal failure (5%)
• Disseminated intravascular coagulation (8%)
• Pulmonary edema (10%)
• Hepatic hemorrhage or rupture (rare)
• Maternal mortality ~1%; perinatal mortality 7–34% (gestational age–dependent)

Diagnostic Criteria

Mississippi Triple-Class Severity Classification

Differential Diagnosis

Note: In HELLP, transaminase elevations rarely exceed 500 IU/L; higher values suggest AFLP.

Biomarker Aids

• sFlt-1:PlGF ratio <38 → negative predictive value 99% for preeclampsia/HELLP within 1 week
• PlGF <100 pg/mL before 35 weeks → rules out need for delivery in 2 weeks with 98% probability

Definitive Treatment

Anesthesia Management

Pre-Anesthetic Assessment

1. Platelet count — mandatory before neuraxial anesthesia; assess trend (stable vs. falling)
2. Coagulation studies — PT, aPTT, fibrinogen; rule out DIC
3. Airway exam — mucosal/laryngeal edema worsens in preeclampsia; failed intubation rate in obstetrics is ~10× higher than non-obstetric patients (1:224–533 attempts)
4. Hemodynamic status — vasospasm + endothelial leak → contracted but porous vasculature
5. Signs of active bleeding — oozing from IV sites, gums, petechiae

Blood Pressure Control (Pre-Anesthetic)

• Treat SBP >160 mmHg or DBP >110 mmHg
• First-line: IV labetalol, IV hydralazine, oral nifedipine
• Avoid methylergonovine (Methergine) — risk of hypertensive crisis
• Patients are sensitive to both endogenous and exogenous catecholamines → use vasopressors cautiously

Magnesium Sulfate

• Administer for seizure prophylaxis/eclampsia treatment
• Anesthetic implications:
  • Potentiates neuromuscular blocking agents (reduce doses and monitor with train-of-four)
  • May cause airway edema
  • Increases risk of postpartum uterine atony (oxytocin augmentation needed)

Regional Anesthesia

Neuraxial Block — Platelet Thresholds

"For patients with preeclampsia, many anesthesiologists are comfortable placing neuraxial blocks with platelet counts as low as 70,000/mm³, provided the count is stable and not falling and that there are no signs of clinical bleeding." — Creasy & Resnik's Maternal-Fetal Medicine

Factors Favoring Neuraxial Despite Borderline Coagulation:

• Concerning airway (predicted difficult intubation)
• Prolonged labor induction anticipated
• Stable, non-falling platelet count ≥70,000/mm³
• No clinical signs of bleeding

Factors Favoring General Anesthesia:

• Clinical signs of active bleeding (oozing at venipuncture sites)
• Rapidly falling platelet count
• Platelet count <50,000/mm³
• Need for urgent/emergent cesarean delivery
• Reassuring airway examination

Fluid Management

• Limit total fluids to 80–100 mL/hr (including MgSO₄ and oxytocin infusions)
• Use conservative preload for surgical neuraxial anesthesia
• No preload for labor analgesia
• Aggressive crystalloid loading does not prevent hypotension and increases risk of pulmonary edema

Spinal vs. Epidural for Cesarean Delivery:

• Spinal anesthesia is safe in preeclamptic patients; previous concerns about hypotension from hypovolemia have not been supported by evidence
• Combined spinal-epidural (CSE) provides flexibility for prolonged cases
• Hypotension from high sympathetic block is managed with judicious vasopressors (phenylephrine preferred; ephedrine acceptable)

General Anesthesia (when regional contraindicated)

Indication-Specific Considerations:

• Platelet count <50,000/mm³, coagulopathy/DIC, patient refusal of neuraxial, or urgent delivery with no time for neuraxial

Airway Management — High Risk in HELLP:

• Upper airway edema is common (preeclampsia) — may worsen with Trendelenburg positioning or pushing
• Have video laryngoscope and supraglottic airway device immediately available
• Most experienced provider should perform laryngoscopy
• Rapid-sequence induction (RSI) is standard:
  • Preoxygenation (3–5 min or 8 vital capacity breaths)
  • Propofol or etomidate for induction; ketamine if hemodynamically unstable (also useful if bronchospasm)
  • Succinylcholine 1.5 mg/kg or rocuronium 1.2 mg/kg for intubation
• Confirm placement with capnography + auscultation
• Failed intubation algorithm: mask ventilation → LMA → fiberoptic bronchoscope → surgical airway

Attenuating the Laryngoscopy Pressor Response:

• IV labetalol 20 mg, IV remifentanil 1 μg/kg, or IV magnesium 30–60 mg/kg (1–1.5 g) before laryngoscopy
• Avoid large doses of ephedrine (may precipitate severe hypertension)

Volatile Anesthetics:

• Provide uterine relaxation (dose-dependent) — use cautiously (<1 MAC) to avoid uterine atony
• High concentrations of desflurane can stimulate catecholamine release — avoid

Emergence:

• Expect continued hemodynamic instability postpartum
• Maintain antihypertensive therapy
• Laboratory derangements may take days to normalize — continued surveillance is mandatory
• HELLP can rarely develop or worsen in the first 48 hours postpartum

Postoperative Considerations

• Continue MgSO₄ for 24–48 hours postpartum (seizure prophylaxis)
• Monitor platelet count, liver enzymes, and LDH q6–12h until trending down
• Blood pressure may spike in the first 3–5 days postpartum (fluid mobilization) — treat BP >140/90 mmHg
• Analgesia: NSAIDs should be used cautiously in the presence of thrombocytopenia or renal impairment; neuraxial opioids (if epidural placed) provide excellent analgesia and reduce systemic opioid requirements
• If platelet count falls postpartum, consider platelet transfusion for count <50,000/mm³ before catheter removal

sFlt-1:PlGF Ratio — What It Means and How to Use It

Background: The Angiogenic Imbalance in Preeclampsia

The Ratio and Its Cutoffs

Clinical Utility

• Increased surveillance frequency
• Maternal corticosteroids for fetal lung maturity
• Planning delivery timing
• ICU/HDU preparation in anesthetic planning

Availability

• Not available for clinical use in the United States (as of current editions)
• Available in the United Kingdom and many European and other countries for routine preeclampsia evaluation
• The NICE guideline and UK RCOG support its use in triage of suspected preeclampsia in secondary care

Practical Takeaway for HELLP Context

• sFlt-1:PlGF < 38 → allows ~1-week safe window, reassurance that delivery is not urgently required for preeclampsia
• sFlt-1:PlGF ≥ 38 (particularly with rising trend) → heightens suspicion for imminent severe preeclampsia/HELLP; triggers expedited delivery planning and anesthetic preparation

Neuraxial Adjuvants — Anaesthetic Implications

Why Adjuvants Are Used

• Prolong duration of block
• Intensify/deepen analgesia or anaesthesia
• Reduce total local anaesthetic dose (and therefore motor block, hypotension, toxicity risk)
• Provide postoperative analgesia beyond the block duration

1. Opioids

Mechanism

• Speed of dural penetration
• Degree of spinal vs. systemic uptake
• Duration and breadth of analgesia
• Side-effect profile

Key Opioids and Doses

Common Side Effects of Neuraxial Opioids

• Pruritus — most common; mediated by central opioid receptors, not histamine. Treat with low-dose naloxone infusion (1–5 μg/kg/h) or nalbuphine. Pruritus from fentanyl is dose-dependent; 5–10 μg intrathecal produces less pruritus than larger doses.
• Nausea and vomiting
• Urinary retention — particularly with intrathecal morphine
• Respiratory depression — most feared. Biphasic with morphine:
  • Early (1–2 h): systemic absorption
  • Delayed (6–18 h): rostral CSF spread to brainstem respiratory centres
  • Risk factors: high dose, opioid-naive, concurrent systemic opioids, obesity, obstructive sleep apnoea, elderly
  • Lipophilic opioids: early depression only; delayed depression rare

Critical rule: Do NOT combine neuraxial opioids with concurrent systemic opioids (e.g., epidural morphine + IV PCA) — additive respiratory depression. — Barash/Stoelting 9e

2. Vasoconstrictors (Epinephrine, Phenylephrine)

Mechanism

• Vasoconstriction of epidural vessels → delays vascular uptake of local anaesthetic/opioid → prolongs block duration
• Direct α2-receptor activation in dorsal horn → additional analgesia
• For intrathecal: α1-mediated vasoconstriction reduces spinal cord blood flow → slower drug clearance

Drug-Specific Effects

Epidural Dose

• Epinephrine 1:400,000 to 1:800,000 (2.5–5 μg/mL) added to labour epidural mixtures
• Higher concentrations avoided due to risk of uterine artery vasoconstriction (obstetric) and systemic cardiovascular effects
• Epinephrine in the epidural test dose (15 μg) detects intravascular catheter placement (heart rate rise >20 bpm within 45 sec)

3. α2-Adrenergic Agonists

Clonidine

• Prolongs duration of subarachnoid and epidural anaesthesia/analgesia
• Reduces local anaesthetic requirements (dose-sparing)
• Effective for neuropathic pain and opioid-tolerant patients

• Intrathecal: 15–45 μg (adjunct to spinal LA)
• Epidural: 75–150 μg bolus; 5–20 μg/h infusion; typically added as 2 μg/mL in infusion

• Hypotension — most clinically significant, especially at higher doses
• Bradycardia — may require atropine
• Sedation — dose-dependent; limits usefulness in outpatients

Dexmedetomidine

• Prolongs intrathecal and epidural block
• Effective adjunct with bupivacaine or ropivacaine for labour analgesia
• Greater analgesia than clonidine at equivalent doses in some studies

• Intrathecal: 5–10 μg
• Epidural: 1–2 μg/mL in infusion mixture

• Bradycardia (requires atropine if significant)
• Hypotension
• Sedation (may be exploited clinically or may be unwanted)

4. Neostigmine (Acetylcholinesterase Inhibitor)

• Produces dose-dependent analgesia
• Abandoned clinically — caused an unacceptable incidence of nausea and vomiting (severe; dose-limiting even at low doses). Further clinical development stopped.

• Reduces local anaesthetic requirements without significant nausea and vomiting
• One RCT comparing epidural neostigmine vs. fentanyl as bupivacaine adjuvant in labour found no difference in bupivacaine consumption
• Not in widespread routine clinical use

5. Ketamine (NMDA Antagonist)

• Intrathecal ketamine: experimental/limited evidence; neurotoxicity concerns with repeated dosing
• Epidural ketamine (preservative-free): used as adjuvant in some settings, particularly for cancer pain and neuropathic pain
• Synergism with neuraxial opioids; may reduce opioid consumption

Summary Table

Practical Anaesthetic Pearls

1. Fentanyl 5–10 μg intrathecal for CSE labour analgesia provides rapid onset; doses above this do not improve analgesia but increase pruritus.
2. Intrathecal morphine 0.1–0.3 mg for post-caesarean analgesia reduces systemic opioid requirements by 50–75%; requires 24-hour respiratory monitoring due to delayed depression risk.
3. Epidural bupivacaine + fentanyl is the most common labour combination; adding epinephrine at 1:400,000–1:800,000 gives modest LA-sparing and prolongs analgesia.
4. Never co-administer neuraxial opioids with systemic opioid PCA — additive respiratory depression.
5. Clonidine/dexmedetomidine: highly effective for refractory pain and opioid-tolerant patients, but haemodynamic monitoring is mandatory; they should not be used as first-line adjuvants in haemodynamically compromised patients.
6. Preservative-free formulations are mandatory for all neuraxial drug administration.

Neuraxial Adjuvants — Anaesthetic Implications

Why Adjuvants Are Used

• Prolong block duration
• Intensify analgesia/anaesthesia
• Reduce total LA dose → less motor block, less hypotension, less toxicity
• Extend postoperative analgesia beyond block duration

1. Opioids

Mechanism

Doses

Side Effects of Neuraxial Opioids

Critical rule: Never combine neuraxial opioids with a concurrent systemic opioid PCA — additive respiratory depression. — Barash/Stoelting 9e

2. Vasoconstrictors (Epinephrine / Phenylephrine)

Mechanism

• Vasoconstriction (α1) of epidural/spinal vessels → delays vascular uptake of LA and opioid → prolongs block
• Direct α2-receptor activation in dorsal horn → additional spinal analgesia
• Intrathecally: reduces spinal cord blood flow → slows drug clearance

Drug-Specific Effects on Block Duration

Dosing

• Epidural labour mixture: epinephrine 1:400,000–1:800,000 (2.5–5 μg/mL)
• Higher concentrations avoided due to uterine artery vasoconstriction risk (obstetrics)
• Epidural test dose: 15 μg epinephrine detects intravascular placement (HR rise >20 bpm within 45 sec)

3. α2-Adrenergic Agonists

Clonidine

• Prolongs subarachnoid and epidural block duration
• Reduces LA consumption
• Particularly effective for neuropathic pain and opioid-tolerant patients

• Intrathecal: 15–45 μg
• Epidural bolus: 75–150 μg
• Epidural infusion: 5–20 μg/h; typically added at 2 μg/mL to infusion mixture

• Hypotension — most clinically significant
• Bradycardia — may require atropine
• Sedation — limits usefulness in ambulatory/outpatient settings

Dexmedetomidine

• More effective than clonidine at equivalent doses in some trials
• Prolongs intrathecal and epidural block
• Effective adjunct with bupivacaine/ropivacaine for labour analgesia

• Intrathecal: 5–10 μg
• Epidural: 1–2 μg/mL in infusion mixture

4. Neostigmine (Acetylcholinesterase Inhibitor)

5. Ketamine (NMDA Receptor Antagonist)

Summary Table

Key Anaesthetic Pearls

1. Fentanyl 5–10 μg intrathecal (CSE/spinal) — doses above 10 μg do not improve analgesia but significantly increase pruritus
2. Intrathecal morphine 0.1–0.3 mg post-caesarean section reduces systemic opioid needs by 50–75%; requires 24-hour respiratory monitoring
3. Epidural bupivacaine + fentanyl ± epinephrine is the standard labour combination; epinephrine at 1:400,000–1:800,000 gives modest benefit without cardiovascular risk
4. Never combine epidural/intrathecal opioid with IV opioid PCA — cumulative respiratory depression
5. Clonidine/dexmedetomidine are most valuable in opioid-tolerant patients and neuropathic pain; always have atropine available
6. All neuraxial drugs must be preservative-free — preservatives (e.g., benzyl alcohol, parabens, bisulfites) are potentially neurotoxic in the intrathecal space